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Proceed With CautionIn a study recently published in the Journal, Dr.
Stretch and colleagues (1) described increasing utili-
zation of short-term mechanical circulatory support
(MCS) in the United States. The investigators found a
dramatic increase in the use of short-term MCS over
the past decade. The NIS (Nationwide Inpatient
Sample), used in this study, is an excellent resource
to study temporal trends on a large scale and is easily
available to researchers. The NIS, however, has limi-
tations that affect the interpretation of this study.
Hospitals are included to approximate a 20% sample
of all hospitals in the United States (2). The weighting
strategy used to create national estimates relies on
the assumption that similar hospitals have similar
experiences (3). This assumption is probably true
for common diagnostic codes, such as pneumonia
and urinary tract infection, but may not be true
for rarer events, such as short-term MCS. In other
words, all rural, large, government, nonteaching
hospitals in the Northeast (1 of 60 hospital strata in
the NIS) will not necessarily adopt MCS at similar
rates. The national estimates, therefore, are prone to
inaccuracy.
The cost methodology used in the NIS is on the basis
of schemas based on primary International Classiﬁca-
tion of Diseases, Ninth Revision, or diagnosticallyrelated groups schemas developed by the Agency
for Healthcare Research and Quality (4). The method-
ology does not directly account for length of stay and
therefore does not account for outlier payments. MCS
patients, however, may be more likely to have long,
complicated hospitalizations and qualify for outlier
payments. The investigators report “other” as the
indication for hospitalization in 20% to 25% of
encounters; the strategy used to calculate costs for this
signiﬁcant group of patients is unclear.
Anecdotal experience suggests that the ﬁndings
of this investigation are true: MCS use is probably
increasing. Still, investigators must ensure rigorous
methods to avoid inaccurate trend assessment.
Research using large datasets, such as the NIS, is
important in understanding health care delivery
trends on a broad scale. This type of research will
become more prevalent and important as adminis-
trative data become more readily available. There-
fore, an increased focus on methods is warranted.*Rashmee U. Shah, MD, MS
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